Patent · US Active

Unit aerosol doses for anticoagulation

US10668015B2 · kind B2 · utility

2Cited by

1References

17Claims

0Family size

Assignees

InCarda Therapeutics, Inc. · US
The Regents of the University of California · US

Inventors

Rangachari Narasimhan · Saratoga, US
Gregory Marcus · Redwood City, US

Key dates

Filing date	Jan 20, 2016
Grant date	Jun 2, 2020
Priority date	—
Expiry date	Jan 20, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are methods for prophylactic treatment of acute coronary syndrome (ACS) comprising administering, by inhalation, an effective amount of a pharmaceutical composition comprising at least one anticoagulant or antiplatelet agent to a subject in need thereof, wherein the anticoagulant or antiplatelet agent first enters the heart via the left atrium.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.